GLP-1 receptor agonists are a class of medications originally developed for type 2 diabetes management and now some are also licensed for weight management
In addition, because the demonstration will operate outside the Part D benefit, the manufacturers wont be responsible for providing the manufacturer price discount on eligible GLP-1s (10% in the Part D initial benefit phase and 20% in the catastrophic phase.) While many prior section 402 demonstrations have had to conform to budget neutrality rules by the Office of Management and Budget (OMB), some demonstrations have been able to move forward without this requirement
Through ongoing support and personalized care, we help patients achieve sustainable results and maintain a healthy lifestyle
Now, you can get curated GLP-ONE Support products in a convenient, money-saving bundle
Newly diagnosed MS patients show evidence of metabolic dysfunctions, such as hyperinsulinemia and reduced insulin sensitivity, Shirani said
Cardiovascular comorbidity in rheumatic diseases